Ortin Global share price
You have to be logged in to add this to Watchlist.- ₹11.47(1.24%)April 23, 2025 12:43:22 PM IST
- NSE
- BSE
- Vol : 0.70K (NSE + BSE)Last 20 day avg : 33.48 K
Ortin Global is trading 1.24% upper at Rs 11.47 as compared to its last closing price. Ortin Global has been trading in the price range of 11.87 & 11.47. Ortin Global has given -36.87% in this year & 2.10% in the last 5 days. The company posted a net profit of -0.11 Crores in its last quarter.Listed peers of Ortin Global include Unjha Formulations (2.01%), Vivanza Biosciences (1.70%), Ortin Global (1.24%).The Mutual Fund holding in Ortin Global was at -% in . The MF holding has - from the last quarter. The FII holding in Ortin Global was at 6.53% in 31 Mar 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Apr 23, 2025, 08:48 AM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BHigher than historical values3.22The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values0.00Price-to-earnings ratio based on trailing 12-month earnings
- BetaHigh volatility1.41Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.64The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is not profitable- The company's revenue fell during December quarter by 75.39% from Rs 0.14 crore to Rs 0.03 crore, year-on-year
The company has reduced its December quarter loss by 96.17% from Rs 2.79 crore to Rs 0.11 crore, year-on-year- The debt to equity of the company is higher than the industry median
- Earnings are insufficient to cover the interest expenses on outstanding debt
- R1
- 11.35
- R2
- 12.71
- R3
- 13.54
- S1
- 9.16
- S2
- 8.33
- S3
- 6.97
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Unjha Formulations | Neutral | 25.38 | 2.01 | 11.37 | 37.97 | 3.86 | - | - |
| Vivanza Biosciences | Neutral | 2.39 | 1.70 | 9.56 | 16.29 | 1.97 | - | 57.82 |
| Ortin Global | Neutral | 11.47 | 1.24 | 9.32 | - | 3.22 | - | 63.82 |
| Hindustan Bio Sciences | Bearish | 8.05 | -4.73 | 8.25 | 149.52 | 10.71 | - | 317.88 |
| Tiaan Consumer | Bullish | 8.37 | - | 18.73 | - | 1.24 | - | - |
- Promoter(s) does not have a high stake in the company
- FIIs are invested in this company
- FIIs holding has increased by 0.28 percentage points from previous quarter
- Mutual Funds are not invested in this company.
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-02-12 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
| 2024-07-31 | Others |
| 2024-05-30 | Audited Results |
- IndustryBiotechnology & Drugs
- ISININE749B01020
- BSE Code539287
- NSE CodeORTINGLOBE
Ortin Global is trading at 11.47 as on Wed Apr 23 2025 07:13:22. This is 1.24% upper as compared to its previous closing price of 11.33.
The market capitalization of Ortin Global is 9.32 Cr as on Wed Apr 23 2025 07:13:22.
The 52 wk high for Ortin Global is 24.96 whereas the 52 wk low is 9.57
Ortin Global can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 28.79
- Dividend Yield: 0.00%
- D/E ratio: -
Ortin Global reported a net profit of -8.04 Cr in 2024.